You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia

    SBC: Irenix Medical, Inc.            Topic: NEI

    PROJECT SUMMARY / ABSTRACTThe objective of this Phase II proposal is to further develop a novel device for ocular anesthesia based on thermo-electric cooling. Intravitreal injection therapy (IVT) is one of the most commonly performed procedures in all of medicine, with approximately 7 million injections in the USA in 2016. Ocular anesthesia is required, both for patient safety and for tolerability ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  2. TOPIC 360: A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER

    SBC: DIAGNOLOGIX, LLC            Topic: NCI

    Chemotherapy may control but rarely cure metastatic cancers. Remarkably, modern immunotherapies, including cell-based therapies, have cured metastatic melanomas and other types of cancers. A major challenge for all cell therapies in general is the need to develop cost-effective and efficient manufacturing and delivery capabilities. We have recently established an innovative cell isolation technolo ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. Prospective evaluation of a surgical solution for breast cancer-associated lymphedema

    SBC: Fibralign Corporation            Topic: 102

    Project Summary/Abstract Prospective evaluation of a surgical solution for breast cancer-associated lymphedema The proposed project will complete remaining key research and technology requirements that are needed to commercialize a ground-breaking interventional device for treating secondary lymphedema -- a chronic and debilitating disease that currently has no cure and impacts an estimated 15-30% ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  4. Development of Innovative Broad-Spectrum Analysis Methods for PFAS

    SBC: SEACOAST SCIENCE, INC.            Topic: 17NCER3A

    This SBIR addresses EPA’s need for improved sampling and analysis technologies to detect Per- and Polyfluoroalkyl Substances (PFAS). PFAS are used in firefighting sprays, at airports, and for wild fires, and have been used in textile treatments (e.g., it is a component in Scotchgard). It is estimated that 65 million Americans are at risk of PFAS exposure in their drinking water. Seacoast propose ...

    SBIR Phase I 2018 Environmental Protection Agency
  5. Greener Plastics with High Heat Tolerance for Additive Manufacturing

    SBC: INTELLIGENT OPTICAL SYSTEMS, INC.            Topic: 17NCER5B

    Advances in materials and automation are rapidly reshaping the American manufacturing economy. These advances must be embraced to sustain a strong manufacturing sector in the United States. Additive manufacturing is possibly the fastest growing example of this trend, growing at an astonishing compound annual growth rate of 25.7%. The plastic materials market for additive manufacturing, valued at $ ...

    SBIR Phase I 2018 Environmental Protection Agency
  6. Indoor Formaldehyde Detection by a Low-Cost Chemical Sensor Based on Organic Nanofibers

    SBC: Vaporsens, Inc.            Topic: 16NCER1A

    Need: People are exposed to formaldehyde, a carcinogen found in building materials. Highly sensitive, real-time formaldehyde sensors would improve human safety by alerting users to harmful concentrations. _x000D_ _x000D_ Technical Feasibility: Vaporsens produces chemical sensors based on novel organic nanofiber technology. Phase 1 results demonstrated high selectivity, rapid-response time, and dem ...

    SBIR Phase II 2018 Environmental Protection Agency
  7. Inexpensive Formaldehyde Sensors for Indoor Air Quality (IAQ) Applications

    SBC: GINER INC            Topic: 16NCER1A

    Recognizing the need to monitor formaldehyde gas in residential and industrial buildings,_x000D_ Giner, Inc. (Giner) will continue the successful work started in Phase I and will develop,_x000D_ fabricate and demonstrate a formaldehyde gas monitor that is capable of continuously_x000D_ measuring formaldehyde in the range of 0-2000 parts per billion (ppb) with a resolution of 10 ppb. The wireless c ...

    SBIR Phase II 2018 Environmental Protection Agency
  8. A GREEN AND UNIQUE THERMOSETTING-THERMOPLASTIC POLYCARBONATE

    SBC: INSTRUMENTAL POLYMER TECHNOLOGIES, LLC            Topic: 16NCER2B

    Of the 300 million tons of plastic produced per year most will require 500 years to biodegrade. Currently only 9% is recycled, and 50 million tons of thermoset plastic produced annually that can't be recycled. _x000D_ _x000D_ This project will develop a sustainable and easily biodegradable polycarbonate plastic that is uniquely a recyclable thermoset resin. We call it a thermosetting thermoplastic ...

    SBIR Phase II 2018 Environmental Protection Agency
  9. Topic 377: Bridging the Guideline Implementation Gap: Clinical Decision Support to Improve Cancer Symptom Management

    SBC: Cognitive Medical Systems, Inc.            Topic: NCI

    Advances in clinical research have yielded many evidence-based guidelines to help clinicians provide the right care for the right patient at the right time; however, studies suggest that nearly half the time, that care does not reach the patient. Clinical decision support (CDS) is an information technology-enabled method to identify missed opportunities and optimize care. This proposal seeks to sy ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  10. Topic 371: Validation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation

    SBC: Riptide Bioscience, Inc.            Topic: NCI

    Radiotherapy, a key anticancer therapy, acts not only by killing cancer cells, but also by activating the body's immune system to attack the remaining cancer cells. However, the immune-stimulating effect is weakened by the tumor's capacity to reprogram immune cells, particularly macrophages, so that they instead actively promote tumor growth. RP-185 (Riptide Biosciences, Vallejo, CA),an engineered ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government